返回
Enlivex Therapeutics Ltd（ENLV）价格
ENLV 股价走势图
ENLV 收益
Enlivex Therapeutics Ltd
$0.94
0.66%
$0
收盘价：Jan 16, 16:00:00 GMT-5
$0.93
-0.71%
$0
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$0.9338
开盘价
$0.97
当日区间
$0.9331 - $0.9863
52周范围
$0.66 - $2.1
交易量
379.2K
平均成交量
3.9M
每股收益（TTM）
-0.55
股息收益率
--
市值
$220.5M
什么是 ENLV？
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.